More about Star Health and Allied Insurance Company Limited
Fundamentals for Star Health and Allied Insurance Company Limited
Regulatory Filings for Star Health and Allied Insurance Company Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Star Health and Allied Insurance Company Limited
Business Operations:
Sector: Financial ServicesIndustry: Insurance - Diversified
Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, star cardiac care insurance policy platinum, young star extra protect add-on cover, antyodaya shramik suraksha yojana, star group domestic travel insurance policy, smart health pro, star domestic travel insurance policy, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of sale persons, insurance marketing firms, and other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.
Revenue projections:
STARHEALTH's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.
Financial Ratios:
| currentRatio | 1.746000 |
|---|---|
| forwardPE | 25.513908 |
| debtToEquity | 6.183000 |
| earningsGrowth | -0.511000 |
| revenueGrowth | -0.412000 |
| grossMargins | 0.205070 |
| operatingMargins | 0.936180 |
| trailingEps | 8.970000 |
| forwardEps | 16.663460 |
STARHEALTH's current ratio being 1.746 suggests the company will have no issues paying off its short-term debt. With sufficient cash reserves and current assets, STARHEALTH can easily cover its immediate liabilities, reflecting solid financial health.
STARHEALTH's Forward PE ratio suggests the stock price is reasonable in relation to earnings. It's not overpriced, providing room for future growth, making the stock a potentially valuable investment for those seeking long-term gains.
STARHEALTH's low growth in earnings and revenue indicates a potential decline in profits. This suggests that the company could be facing financial challenges, making it harder to sustain its current profit margins.
STARHEALTH's negative gross and operating margins indicate that the company is currently unprofitable at both the production and operational levels. This suggests significant challenges in managing costs and generating revenue, which could impact its overall financial health.
STARHEALTH's forward EPS being higher than its trailing EPS signals anticipated growth in profitability for the current financial year. This suggests that STARHEALTH is on track to improve its earnings, outpacing the previous year's performance and reflecting positive market expectations.
Price projections:
Star Health and Allied Insurance Company Limited's price has frequently been situated near the lower end of analysts' projections. This trend indicates that the stock is struggling to meet expectations, which could signal a need for improvements in performance or investor confidence.
Insider Transactions:
6 separate transactions to buy STARHEALTH were completed, while market price hovered around 474.1333312988281.No buy transactions occurred in the period under review.The higher volume of sells at Star Health and Allied Insurance Company Limited's current price levels could indicate a potential decline. If this selling trend persists, the stock might continue to fall as investor confidence wanes, leading to more downward pressure.
Recommendation changes over time:
STARHEALTH has garnered a buy bias from analysts recently, suggesting the stock is a good investment opportunity. This may lead to increased investor interest, as STARHEALTH is seen as a reliable place to park money for those looking to benefit from potential market gains and company growth.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction